首页|期刊导航|中国食品药品监管|检察机关网络销售处方药公益诉讼的实证研究与监管启示

检察机关网络销售处方药公益诉讼的实证研究与监管启示OA

Empirical Study and Regulatory Implications of Procuratorial Public Interest Litigation Concerning Online Sales of Prescription Drugs:An Analysis Based on Cases from 2019 to 2025

中文摘要英文摘要

本文以2019~2025年最高人民检察院及地方检察机关公布的网络销售处方药公益诉讼案例为样本,系统梳理制度演进、案件类型、监督重点与裁判规则,总结检察机关在规范网络销售处方药经营、强化平台监管、打击违法售药等方面的实践成效.在此基础上,从监管协同、制度完善、技术赋能、社会共治等维度,提出进一步提升网络销售处方药监管效能、保障公众用药安全的启示,为构建全链条、全周期的药品安全治理体系提供参考.

Based on cases of public interest litigation concerning online sales of prescription drugs released by the Supreme People's Procuratorate and local procuratorates from 2019 to 2025,this study systematically reviews institutional developments,case types,supervisory priorities,and adjudication rules,and summarizes the practical achievements of procuratorial authorities in regulating online sales of prescription drugs,strengthening platform regulation,and combating illegal drug sales.On this basis,regulatory implications are proposed from four dimensions:regulatory coordination,institutional improvement,technical empowerment,and social co-governance,to further improve the regulatory effectiveness of online sales of prescription drugs and ensure public medication safety.These findings provide a reference for building a full-chain and full-cycle drug safety governance system.

吴利雅;佟婳

中国药品监督管理研究会国际关系学院经济金融学院

社会科学

网络销售处方药公益诉讼检察机关药品监管案例

online sales of prescription drugspublic interest litigationprocuratorial authoritiesdrug regulationcases

《中国食品药品监管》 2026 (9)

22-27,6

2025年中国药品监督管理研究会课题(2025-G-Y-004)

10.3969/j.issn.1673-5390.2026.09.002

评论